Abiopharma

🔍 Kennedy Michael N. (Director)

Company: ANTERO RESOURCES Corp (AR)

Report Date: 2026-05-04

Detailed Transactions and Holdings:

• Sold 170,740 shares of Common stock, par value $0.01 per share at $39.31 per share (Direct)
  Date: 2026-05-04 | Code: S | equity_swap_involved: 0 | shares_owned_after: 1,100,278.00 | transaction_form_type: 4 | Footnotes: F1, F2, F4
• Sold 15,086 shares of Common stock, par value $0.01 per share at $39.61 per share (Direct)
  Date: 2026-05-04 | Code: S | equity_swap_involved: 0 | shares_owned_after: 1,085,192.00 | transaction_form_type: 4 | Footnotes: F1, F3, F4

Footnotes:

• F1: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 6, 2025.
• F2: The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $38.57 to $39.56, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2) and (3).
• F3: The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $39.57 to $39.75, inclusive.
• F4: Includes 172,117 shares of common stock of the Issuer subject to restricted stock units awards and 70,747 performance share units in respect of which performance has been certified, in each case that remain subject to service-based vesting.
• REMARKS: Chief Executive Officer & President